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ABSTRACT
Background: Toll-like receptors (TLRs) are structurally
and functionally related and play important roles in the
innate and adaptive immune system. By genome
scanning, evidence of linkage between chromosome Xp22
and asthma and related atopic disorders has previously
been obtained. Xp22 harbours the TLR7 and TLR8 genes.
Methods: The involvement of TLR7 and TLR8 in the
aetiology of asthma and related disorders was investi-
gated by a family based association analysis of two
independently ascertained family samples comprising 540
and 424 individuals from 135 and 100 families,
respectively. Ten affected individuals from families
showing evidence of linkage to Xp22 were screened for
sequence variations in TLR7 and 8, and nine single
nucleotide polymorphisms (SNPs) identified were tested
for association.
Results: In both samples, significant associations were
observed for single SNPs and haplotypes of both TLR7
and 8 in all four phenotypes investigated: asthma, rhinitis,
atopic dermatitis and increased specific IgE. The most
significant association was seen for rs2407992 (TLR8) in
asthma (p = 0.00023, sample A and B combined,
recessive model). In TLR7, rs179008 showed the
strongest association. Both rs179008 and rs2407992 are
of putative functional significance, potentially affecting
TLR7 processing and TLR8 splicing, respectively.
Haplotypes comprising the major alleles of these two
SNPs were overtransmitted to the affected offspring (eg,
p = 0.00012 in asthma, combined sample, additive
model).
Conclusion: The results provide strong evidence that
TLR7 and 8 may confer susceptibility to asthma and
related atopic disorders and highlight these receptors as
interesting targets for individualised, causally directed
treatment.
Allergic disorders such as asthma, rhinitis and
atopic dermatitis constitute a high incidence global
health problem that affects an increasing number
of individuals who are often faced with a
considerable loss in quality of life. When possible,
the typical countermeasure is to avoid contact
with known allergens. When this is not possible,
however, the only option is medical treatment,
which currently aims at modulating general
immunological/inflammatory responses, often at
the price of adverse side effects. A more focused
treatment is dependent on a more detailed knowl-
edge of the aetiology of the diseases.
The diseases are complex and depend on multi-
ple poorly defined environmental as well as genetic
factors. The genetic component, which is poly- or
oligogenic in nature, is considerable, as evidenced
by several family and twin studies.1–5
Several genome scans have been conducted,
suggesting a number of susceptibility loci for
allergic disease.6 We have obtained evidence of
linkage to chromosome Xp22 for atopic pheno-
types, including asthma, atopic dermatitis and
rhinitis.7–9 Xp22 harbours two members of the Toll-
like receptor family (TLR7 and 8), which play a
central role in the immune response. TLRs are key
receptors among germline encoded pattern recog-
nising receptors that play a major role in the
recognition of microbial pathogens and initiation
of the innate and adaptive immune response. They
have emerged relatively late on the stage of
identified immunological players as their role in
pathogen sensing was not really appreciated until
1998, when the gene at the locus responsible for
recognising lipopolysaccharide (a cell wall compo-
nent of gram negative bacteria) was cloned and
found to be identical to TLR4.10 Since then, a
plethora of microbial derived ligands, collectively
known as pathogen associated molecular patterns,
as well as a handful of host derived ligands, have
been found to trigger TLR signalling through one
or more of the 10 TLRs (TLR1–10) so far identified
in humans.
TLRs are expressed in various immune cells,
including antigen presenting cells and cells that are
likely to experience first encounter with incoming
pathogens (eg, epithelial cells). Antigen presenting
cells and particularly dendritic cells are important
in the initial pathogen sensing and initiation of the
immune response. Dendritic cells play a critical role
in the crossroad between innate and adaptive
immunity by controlling signals that direct naive
T helper (Th) cells to differentiate into either Th1
or Th2 cells. Whether dendritic cells promote a Th1
or Th2 state, characterised by distinct cytokine
profiles, depends to a large extent on which and
how TLRs are triggered, which again depends on
the type of infection.11 12 In type I allergy and
atopy, the Th1/Th2 balance is skewed towards a
Th2 state characterised by an IgE hyper-produc-
tion, and the potential of TLRs for decisive
regulation of immune responses has brought
considerable focus on these receptors in the search
for an aetiological understanding of allergy and
atopy.13 In the specific context of asthma and
related allergies, attention has been given to TLR2
and TLR4 as receptors of peptidoglycan from gram
positive bacteria and lipopolysaccharide, respec-
tively,14 whereas comparably little attention has
been given to TLR7 and TLR8.
TLR7 and TLR8 are homologues and have TLR9
as their closest evolutionary relative.15 16 They
both have affinity towards single stranded RNA
and similar signalling characteristics but differ
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somewhat in tissue expression patterns.15–19 TLR7 and TLR8 are
not expressed on the cell surface but are found in endosomal
compartments (like TLR3 and TLR9) and their activation
requires endocytosis of the pathogens. In a study investigating
TLR expression in activated monocyte-like THP-1 cells, it was
reported that TLR7 and TLR8 had the strongest overall
upregulation in expression in response to classic innate
immunity cytokines as well as live bacteria.20
We here report the results from a family based association
study investigating the positional and functional candidate
genes TLR7 and 8 in relation to asthma, rhinitis, atopic
dermatitis and increased specific IgE (positive RAST test) in
two independently ascertained samples from Denmark.
METHODS
Subjects
Two independently ascertained family samples (A and B) were
investigated (table 1). Informed consent was obtained from each
participant prior to inclusion in the study. Local ethics
committee approval was obtained in all regions where families
were recruited.
Sample A included 135 nuclear families with sib pairs who
had asthma, who were enrolled from four clinical centres in
eastern, western and central parts of Denmark, primarily on the
basis of patient records. Criteria for inclusion were recurrent
cough, wheezing and dyspnoea as well as a positive metacholine
challenge measured using the methods described by Yan et al.21
The affected siblings were between 15 and 45 years of age. Lung
function measurements including forced expiratory volume in
1 s and forced vital capacity were performed on all subjects.
Blood samples were analysed for allergen specific IgE (CAP
phadiatop; Pharmacia Upjohn, Copenhagen, Denmark); a
positive test was defined as IgE >0.35 kUA/l for at least one
of the allergens. Rhinitis and atopic dermatitis phenotypes were
recorded on the basis of questionnaires. Details about the
sample have been reported previously.22
Sample B comprised 100 Danish atopic families, including a
total of 424 individuals enrolled in the ITA project via four
paediatric and one adult outpatient allergy clinic in western
Denmark. Recruitment, examination and clinical information
have been described previously.7 23 In brief, inclusion criteria
were a minimum of two atopic siblings with doctor diagnosed
asthma, rhinitis or atopic dermatitis and a reported effect of
appropriate medication. All subjects were examined clinically
and questionnaire tested by the same doctor who diagnosed the
patients according to standard criteria in consensus with a
second doctor evaluating the questionnaires only. The most
common diagnosis was asthma affecting 70% of the siblings
(table 1). Mean age among the offspring was 10.8 years. Blood
samples were taken for DNA extraction and serum measure-
ment of specific IgE to 11 common allergens (CAP RAST FEIA;
Pharmacia Upjohn); a positive test was defined as above.
Both samples had a male/female ratio not diverging sig-
nificantly from random distribution.
Sequencing and genotyping
Blood samples were used for preparation of genomic DNA
according to standard procedures. In order to increase the
chance of identifying causal risk alleles, 10 patients from
families showing evidence of linkage to Xp22 in previous
studies7–9 were selected for sequence analysis of TLR7 and 8. Of
the 10 patients sequenced, seven were females (ie, 17 X
chromosomes were analysed). The TLR genes were screened
for sequence variation in the coding sequence and intron/exon
boundaries as well as in the promoter region (approximately
1000 bp of the upstream region) by direct sequencing using Big
Dye Terminator Cycle Sequencing Kit (Applied Biosystems,
Foster City, California, USA). Following ethanol precipitation,
the sequencing reactions were analysed on an ABI-310
sequenator (Applied Biosystems). Both strands were analysed.
The single nucleotide polymorphisms (SNPs) identified were
subsequently genotyped in the two family samples, using the
SNaP-shot single base extension technology (Applied
Biosystems). Standard PCR conditions were used for both
sequencing and genotyping. Primers are available on request.
The genotypes were scored independently by two experienced
investigators and tested for Mendelian inheritance.
Statistical analysis
The program FBAT V.2.0.2c24 25 was used for family based
association analysis of single SNPs and haplotypes. In the
haplotype analysis, p values were obtained for individual
haplotypes as well as for the overall/global distribution of all
haplotypes of a specific marker segment. A sliding window
approach was applied analysing segments of neighbouring
SNPs. Because of prior evidence of linkage observed in both
samples,7–9 the empirical variance (-e option in the FBAT
program) was used in all calculations to account for genotype
Table 1 Data for the two family samples
Asthma Rhinitis
Atopic
dermatitis
Positive
RAST
Sample A (135 families)
Families with one affected child 0 47 51 35
Families with two affected children 135 74 68 73
Total families 135 121 119 108
Total affected siblings (% of total) 270 (100) 195 (72) 187 (69) 181 (67)
Sex ratio M:F in Phenotype (total = 0.8) 0.8 0.6 0.7 0.8
Sample B (100 families)
Families with one affected child 31 36 33 36
Families with two affected children 45 35 34 40
Families with three affected children 12 8 6 7
Total families 88 79 73 83
Total affected siblings (% of total) 157 (70) 130 (58) 119 (53) 137 (61)
Sex ratio M:F in Phenotype (total = 1.2) 1.4 1.2 1.2 1.2
Sample A: mean age of siblings 28 years, mean forced expiratory volume in 1 s 3.5 l. Sample B: mean age of siblings 10.8 years.
RAST, radioallergosorbent test.
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correlation among affected sib pairs that result from linkage,
thus testing the null hypothesis ‘‘linkage but no association’’.
The data were analysed using an additive model, which does
not assume any specific mode of inheritance and is in general
the most sensitive test.24 The additive model is equivalent to the
classic transmission disequilibrium test.26 However, power
calculations using PBAT27 28 revealed that a recessive model
would have the strongest power in our samples. For example,
analysis of SNP1 in sample A would have a power of 0.899
under the additive model whereas the recessive model resulted
in a power of 1 (assuming a significance level of 0.05, a population
prevalence of the disease of 0.1 and a genetic attributable fraction
of 0.2). Therefore, we also analysed the data assuming a recessive
mode of inheritance. As the majority of tests performed were not
independent, the p values reported are not corrected for multiple
testing. However, the most significant single SNP and haplotype
results survive a Bonferroni correction.
The degree of linkage disequilibrium (LD) between the SNPs in
our samples was calculated using the program Haploview, which
creates a maximal set of unrelated individuals, using family data
only for parent/offspring phasing.29 This program was also used to
assess the LD pattern of the X chromosomal region of interest in
the CEPH population (CEU) using SNP genotype data from the
HapMap project (http://www.hapmap.org/).
Table 2 Single nucleotide polymorphisms (SNPs) investigated
Gene
(cytogenetic
position)
SNP
number in
this study
rs Number
(major/minor allele) Position
Position in
gene, subst
MAF
A B
TLR7 (Xp22) 1 rs179008 (A/T) 12813580 Ex3, Q11.L T: 0.24 0.21
2 rs5743781 (C/T)* 12814891 Ex3, A448.V T: 0.012 0.003
3 rs864058 (C/T) 12815951 Ex3, syn T: 0.074 0.11
TLR8 (Xp22) 4 rs5741883 (C/T) 12834142 Promoter T: 0.25 0.20
5 rs3764879 (C/G) 12834618 Promoter G: 0.24 0.24
6 rs3764880 (A/G) 12834747 Ex1, M1.V G: 0.21 0.22
7 rs5744077 (A/G)* 12847108 Ex2, M10.V G: 0.002 0
8 rs2159377 (C/T) 12847434 Ex2, syn T: 0.19 0.15
9 rs2407992 (G/C) 12849033 Ex2, syn C: 0.42 0.38
Position according to UCSC (http://genome.ucsc.edu/, Mar. 06 assembly).
*SNPs included from dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/).
MAF, minor allele frequency; TLR, Toll-like receptor.
Figure 1 Linkage disequilibrium (LD) in the Toll-like receptor (TLR)7–TLR8 region based on the CEU population (HapMap data) represented as r2. LD
blocks are calculated from D9.34 Arrows mark positions of TLR7 and TLR8 single nucleotide polymorphisms (SNPs) used in this study (rs5743781 and
rs5744077 are not included as they are not polymorphic in the CEU population).
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In silico analysis
The program MatInspector (www.genomatix.de)30 31 was used
to analyse potential transcription factor binding sites around
SNPs located in the promoter regions. To assess the possible
effect of synonymous SNPs, we used FastSNP.32 The SignalP 3.0
server (http://www.cbs.dtu.dk/services/SignalP/)33 was used to
predict and analyse changes in the signal sequences for SNPs
located in the N terminal end of the protein.
RESULTS
Sequencing of 10 individuals from families showing evidence of
linkage to Xp22 revealed seven SNPs in the TLR7 and TLR8
genes (table 2). In addition, two non-synonymous SNPs from
the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/
SNP/) were added to the study. However, these SNPs were very
rare in our samples (table 2). For all SNPs, the genotype
distribution was found to be in Hardy–Weinberg equilibrium
among the parents in both samples.
Linkage disequilibrium
The nine SNPs investigated spanned a 35 kb region containing
the TLR7 and TLR8 genes located head to tail (fig 1). A relatively
low degree of LD was found except for one pair (SNP5–SNP6 in
the TLR8 gene) displaying r2 values of 0.7–0.9 (table 3), which is
consistent with the low LD seen across the region in the CEU
population (fig 1).
Association analysis
Association with asthma and related phenotypes was found for
SNPs and haplotypes in both independent samples. SNP1 and 9
corresponding to rs179008 (TLR7) and rs2407992 (TLR8),
respectively, showed the strongest and most consistent associa-
tion (table 4 and supplementary table 1 online), both showing
association with all tested phenotypes. In each sample,
significant associations were observed for SNP9 (TLR8) in
asthma whereas SNP1 showed significant associations only in
sample B (and merely a trend towards association in sample A).
Overall, the most significant results were found for SNP9
(TLR8) in asthma (p = 0.00023) and atopic dermatitis
(p = 0.00066) in the two samples combined under a recessive
model.
Because TLR7 and TLR8 are located on the X chromosome, we
analysed boys and girls separately as well as combined. This
revealed some differences in the association pattern. Association
Table 3 Linkage disequilibrium (r2) between TLR7 and TLR8 SNPs for sample A and B
Gene SNP S1 S2 S3 S4 S5 S6 S7 S8 S9
TLR7 rs179008 (S1) N 0.03 N N N N 0.01 0.02
TLR7 rs5743781 (S2) N N N N N N N N
TLR7 rs864058 (S3) N N N N 0.01 N 0.03 0.02
TLR8 rs5741883 (S4) 0.05 N 0.01 0.06 0.04 N 0.01 0.03
TLR8 rs3764879 (S5) N N 0.01 0.08 0.7 N 0.3 0.1
TLR8 rs3764880 (S6) N N N 0.07 0.9 N 0.2 0.08
TLR8 rs5744077 (S7) N N N N N N N N
TLR8 rs2159377 (S8) 0.03 N 0.03 0.01 0.4 0.3 N 0.2
TLR8 rs2407992 (S9) N N 0.01 0.01 0.2 0.2 N 0.3
Sample A in top right corner of table, sample B in bottom left corner.
Nr2,0.01.
SNP, single nucleotide polymorphism; TLR, Toll-like receptor.
Table 4 Association analysis of TLR7 and TLR8 SNPs
Asthma Rhinitis Atopic dermatitis Positive RAST
Additive Recessive Additive Recessive Additive Recessive Additive Recessive
Sample A
SNP1 (TLR7) 0.066
AOT
SNP9 (TLR8) 0.054 0.047 0.074 0.019 0.058
GOT 0.018 (G) 0.0071 (G) 0.016 (G) 0.046 (G) 0.025 (G)
Sample B
SNP1 (TLR7) 0.012 (B) 0.056 0.013 0.0071 0.027 0.0090
AOT 0.012 (B) 0.0054 (B) 0.0054 (B) 0.020 (B) 0.020 (B) 0.011 (B) 0.011 (B)
SNP9 (TLR8) 0.00069 0.00053 0.066 0.052 0.083 0.061
GOT 0.0035 (B) 0.0035 (B)
0.046 (G) 0.059 (G)
Sample A+B
SNP1 (TLR7) 0.069 0.018 0.025 0.0053 0.074 0.0047 0.0044
AOT 0.0092 (B) 0.0092 (B) 0.0039 (B) 0.0039 (B) 0.024 (B) 0.024 (B) 0.0052 (B) 0.0052 (B)
SNP9 (TLR8) 0.00025 0.00023 0.033 0.012 0.021 0.00066 0.063 0.014
GOT 0.035 (B) 0.035 (B) 0.037 (G) 0.069 (G) 0.016 (G) 0.0077 (G)
0.0020 (G) 0.0010 (G)
Only p values ,0.1 are included in the table. p Values (0.05 are indicated in bold type.
B and G, boys and girls, respectively (values with no letter represent the total); OT, overtransmitted allele; RAST, radioallergosorbent test; SNP, single nucleotide polymorphism;
TLR, Toll-like receptor.
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with SNP1 was strongest in boys while association with SNP9
seemed more or less the same in boys and girls, although the
girls produced the strongest signal in sample A. Evidence of
association was also seen for rs5741883 (SNP4 in TLR8) among
girls with rhinitis in sample A (p = 0.033, recessive).
The haplotype analysis assessing adjacent SNPs in a sliding
window fashion revealed several significant results some of
which are shown in supplementary table 2A and 2B (available
online). Overall, the results supported the single SNP analysis.
Moreover, significant associations were seen in sample A
between TLR7 and increased specific IgE (RAST positive) that
were not revealed in the single SNP analysis, thereby providing
TLR7 association in both samples for this phenotype. Likewise,
significant associations were seen in both samples for identical
individual haplotypes encompassing SNPs from both TLR7 and
8 (eg, SNP1–4 haplotypes in rhinitis and positive RAST).
Specific haplotype analysis of SNP1 and 9 showed association in
all phenotypes. The haplotype comprising the two major alleles
(TG) was overtransmitted, most significantly in asthma
(p = 0.00012, combined sample, additive model).
In conclusion, replication of allelic association for SNPs
(TLR8) or individual haplotypes (TLR7/8) was obtained for all
four phenotypes investigated in the two samples.
In silico analyses
SNP1 in TLR7 (rs179008) is a non-synonymous change, altering
a Gln residue to a Leu residue in the signal peptide sequence of
TLR7 at amino acid position 11. SignalP 3.0 identified distinct N,
H and C regions along the signal sequence (H for hydrophobic)
and the most probable cleavage site between residue 26 and 27.
According to this prediction, the Gln 11 constitutes the last
amino acid in the N region within the signal sequence.
Changing Gln11 to Leu shortens the N region and extends the
H region, indicating that this substitution polymorphism may
affect the processing of TLR7.
SNP4 in TLR8 (rs5741883) is located in the promoter region
where it affects potential transcription factor binding sites
according to the MatInspector program. In the presence of the C
allele, a binding sequence for the aryl hydrocarbon receptor
(AhR)/AhR nuclear translocator (ARNT) heterodimer is
formed. The AhR is implicated in mediating responses to
various xenobiotics, such as dioxin and polychlorinated biphen-
yls, which have been reported to alter the cellular and humoral
immune responses.35 In the presence of the T allele, a binding
sequence for the Atp1a1 regulatory element binding factor 6 is
formed. This transcription factor has been shown to regulate
the expression of interleukin 2,36 which has recently been
associated with allergic diseases and atopy.37
The synonymous TLR8 SNP9 (rs2407992) was analysed using
FastSNP. According to this, there is a medium to high risk of
rs2407992 affecting the splicing by abolishing a splice enhancer
domain.
DISCUSSION
In this study, we have examined the possible role of TLR7 and
TLR8 on the X chromosome in the aetiology of asthma and
related disorders by conducting a family based association study
of two Danish samples involving 540 and 424 individuals,
respectively. In the two independently ascertained family
samples, replicated association was obtained for SNPs or
haplotypes of TLR7 and TLR8, suggesting these genes as novel
disease genes for asthma and related disorders.
The general pattern of allelic and haplotypic transmission
distortion was the same for the two samples and the four
phenotypes investigated. However, some difference regarding
the degree/significance of the transmission distortions was
evident (table 4 and supplementary table 2A, B online). This
could be because of sample heterogeneity originating from
demographic and clinical differences between sample A and B.
The siblings in sample A were older than 15 years whereas the
probands in sample B were primarily children. Other inclusion
criteria and diagnostics were not completely the same either.
Thus even though the diagnoses are the same, the susceptibility
alleles might not be of equal significance in the two samples.
Furthermore, some gender differences were observed. In
particular, SNP1 and TLR7 haplotypes showed most significant
association in boys, suggesting a predominantly recessive effect
of these variants.
The region harbouring TLR7 and 8 is characterised by a very
low degree of LD (fig 1, table 3), indicating that the associations
observed represent separate independent signals in TLR7 and 8,
respectively. For instance, the two SNPs showing the most
significant results, SNP1 (TLR7) and SNP9 (TLR8), display an
intermarker r2 of around 0.01. Furthermore, LD analysis of data
provided by the HapMap project shows that there is practically
no LD between the TLR7 and 8 genes and flanking genes,
making the possibility that the signals observed are caused by
LD to neighbouring disease genes highly unlikely.
SNP1 (rs179008, TLR7) is non-synonymous changing a Gln to
a Leu in the signal sequence, thereby extending the H region and
shortening the N region, as mentioned. In general, there is a
high degree of degeneracy in endoplasmic reticulum (ER) signal
sequences, which at first glance may reflect a high versatility of
the translocation and ER import machinery. However, a
number of studies suggest that correct processing of proteins
at the ER membrane depends on protein specific sequence
specificity within the signal sequences. Thus mutation of the
signal sequence has been shown to affect secretion and
translocation efficiencies,38 39 post translational processing
events such as glycosylation38 and even membrane integration
and topology.40 41 Thus even though our theoretical knowledge
is not yet sufficient to accurately predict the consequences of
the rs179008 variation, it is likely that it somehow affects the
processing of TLR7 at the ER membrane.
Likewise, the in silico analyses suggested functional impacts
of SNP4 and SNP9 on TLR8 expression and splicing, respec-
tively. These results support the causal relationship and should
be scrutinised experimentally. Alternatively, the SNPs might be
LD proxies for causal SNPs that were not detected in the
sequence screening. However, analysing HapMap SNPs, no
(common) SNPs in tight LD with the associated SNPs of the
present study seem to be of likely functional significance (data
not shown).
Interestingly, two recent studies have found rs179008 (SNP1,
TLR7) associated with age related macular degeneration and
chronic hepatitis C virus infection, respectively, thus indicating
that this variant may be involved in susceptibility to a broad
range of inflammatory phenotypes.42 43 Furthermore, an SNP in
intron 1 of TLR7 has been reported to protect against advanced
inflammation and fibrosis in male patients with chronic HCV
infection.44
Our results strongly suggest that TLR7 and TLR8 are novel
risk genes in asthma and related atopic disorders. Several non-
genetic lines of evidence support the involvement of these two
TLRs in immune related diseases and suggest these two TLRs as
potential drug targets. Of particular interest, it has recently
Asthma
1068 Thorax 2008;63:1064–1069. doi:10.1136/thx.2007.094128
been shown in murine models that the synthetic TLR7/TLR8
ligand resiquimod (R-848, S-28463) is effective in preventing the
development of the asthmatic phenotype as well as inhibiting
an inflammatory reaction in response to allergens when the
asthmatic phenotype has been established.45–47 Considering the
results of the present study, treatment with TLR7/8 ligands
should be causally directed and holds promise for genetically
based individualised treatment of these common disorders.
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